Hyperdynamic Circulation of Cirrhotic Rats: Role of Substance P and Its Relationship to Nitric Oxide

References

• Vorobioff J, Bredfeldt J E, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52–7
   PubMed Web of Science ®Google Scholar
• Groszmann R J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepa-tology 1994; 20: 1359–63
   PubMed Web of Science ®Google Scholar
• Pizcueta P, Piqué J M, Fernández M, Bosch J, Rodés J, Whittle BJR, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909–15
   PubMed Web of Science ®Google Scholar
• Sieber C C, Groszmann R J. In vitro hyporeactivity to mefhox-amine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262: G996–1001
   PubMedGoogle Scholar
• Lee F Y, Albillos A, Colombato L A, Groszmann R J. The role of nitric oxide in the vascular hyporesponsiveness to mefhoxamine in portal hypertensive rats. Hepatology 1992; 16: 1043–8
   PubMed Web of Science ®Google Scholar
• Lee F Y, Colombato L A, Albillos A, Groszmann R J. Nw-nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17: 84–90
   PubMed Web of Science ®Google Scholar
• Pizcueta M P, Pique J M, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184–90
   PubMed Web of Science ®Google Scholar
• Withrington P G. The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds. Br J Pharmacol 1992; 107: 296–302
   PubMed Web of Science ®Google Scholar
• Melchiorri P, Tonelli F, Negri L. Comparative circulatory effects of substance P, eledoisin and physalamin in the dog. Substance P, US Von Euler, B Pernow. Raven, New York 1977; 311–9
   Google Scholar
• Iverson L L. Substance P. Br Med Bull 1982; 38: 277–82
   PubMed Web of Science ®Google Scholar
• Kabemura T, Misawa T, Chijiiwa Y, Nasu T, Nawata H. Substance P, vasoactive intestinal polypeptide, and gastrin catabol-ism in canine liver and kidney. Dig Dis Sci 1992; 37: 1661–5
   PubMed Web of Science ®Google Scholar
• Ueno T, Inuzuka S, Torimura T, Sakata R, Sakamoto M, Gondo K, et al. Distribution of substance P and vasoactive intestinal peptide in the human liver: light and electron immunoperoxidase methods of observation. Am J Gastroenterol 1991; 86: 1633–7
   PubMed Web of Science ®Google Scholar
• Saito R, Nonaka S, Konishi H, Takano Y, Shimohigashi Y, Matsumoto H, et al. Pharmacological properties of the tachykinin receptor subtype in the endothelial vasodilatation. Ann NY Acad Sci 1991; 632: 457–9
   PubMed Web of Science ®Google Scholar
• Hörtnagl H, Singer E A, Lenz K, Kleinberger G, Lochs H. Substance P is markedly increased in plasma levels of patients with hepatic coma. Lancet 1984; 1: 480–3
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Parent R, Lavallée M. Disparate effects of substance P on systemic and coronary beds in conscious dogs. Circulation 1991; 84: 300–12
   PubMed Web of Science ®Google Scholar
• Lee F Y, Wang S S, Yang MCM, Tsai Y T, Wu S L, Lu R H, et al. Role of endotoxemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J Gastroenterol Hepatol 1996; 11: 152–8
   PubMed Web of Science ®Google Scholar
• Chiang J H, Cheng H C, Yang MCM, Lo J G, Chi C W, Lui W Y, et al. Lung deposit of lipiodol in normal and cirrhotic rats. Acta Radiol 1991; 32: 474–8
   PubMed Web of Science ®Google Scholar
• Albillos A, Colombato L A, Groszmann RJ. Vasodilatation and sodium retention in prehepatic porta! hypertension. Gastroenterology 1992; 102: 931–5
   PubMed Web of Science ®Google Scholar
• Stuehr D J, Marietta M A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738–42
   PubMed Web of Science ®Google Scholar
• Marietta M A, Poksyn S Y, Iyengar R, Leaf C D, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706–11
   PubMed Web of Science ®Google Scholar
• Langrehr J M, Murase N, Markus P M, Cai X, Neuhaus P, Schraut W, et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992; 90: 679–83
   PubMed Web of Science ®Google Scholar
• Guarner C, Soriano G, Tomas A, Bulbena O, Novella M T, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139–43
   PubMed Web of Science ®Google Scholar
• Hunt NCA, Goldin R D. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol 1992; 14: 146–50
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Schaffalitzky de Muckadell O B, Billow JB. Does liver-intestine significantly degrade circulating endogenous substance P in man? Scand. J Gastroenterol 1986; 21: 300–4
   Web of Science ®Google Scholar
• Fernández-Rodriguez C M, Prieto J, Quiroga J, Zozoya J M, Andrade A, Núñez M, et al. Plasma levels of substance P in liver cirrhosis: relationship to activation of vasopressor systems and urinary sodium excretion. Hepatology 1995; 21: 35–40
   PubMed Web of Science ®Google Scholar
• Mantyh P W, Pinnock R D, Downes C P, Goedert M, Hunt SP. Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature 1984; 309: 795–7
   PubMed Web of Science ®Google Scholar
• Hall J M, Brain S D. Inhibition by SR 140333 of NK, tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vitro. Br. J Pharmacol 1994; 113: 522–6
   Google Scholar
• Petersson J, Zygmunt P M, Brandt L, Högestätt E D. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol 1995; 115: 889–94
   PubMed Web of Science ®Google Scholar
• Zhang G, Yamamoto Y, Miwa K, Suzuki H. Vasodilatation induced by substance P in guinea pig carotid arteries. Am J Physiol 1994; 266: H1132–7
   Google Scholar
• Schrier R W, Arroyo V, Bernardi M, Epstein M, Henriksen J H, Rodés J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151–7
   PubMed Web of Science ®Google Scholar
• Dudley F J. Pathophysiology of ascites formation. Gastroenterol Clin North Am 1992; 21: 215–35
   PubMed Web of Science ®Google Scholar
• Granger D N, Taylor A E. Permeability of intestinal capillaries to endogenous macromolecules. Am J Physiol 1980; 238: H457–64
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Parving H-H, Christiansen L, Winkler K, Lassen NA. Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver. Scand J. Clin Invest 1981; 41: 289–99
   Google Scholar
• Witte C L, Chung Y C, Witte M H, Sterle O F, Cole WR. Observations on the origin of ascites from experimental extrahepatic portal congestion. Ann Surg 1969; 170: 1002–15
   PubMed Web of Science ®Google Scholar
• Witte C L, Myers J F, Witte M H, Katz M A. Transcapillary water and protein flux in the canine intestine with acute and chronic extrahepatic portal hypertension. Circ Res 1983; 53: 622–9
   PubMed Web of Science ®Google Scholar
• Korthuis R J, Kinden D A, Brimer G E, Slattery K A, Stogsdill P, Granger D N. Intestinal capillary filtration in acute and chronic portal hypertension. Am J Physiol 1988; 254: G339–45
   Google Scholar
• Nguyen L S, Villablanca A C, Rutledge JC. Substance P increases microvascular permeability via nitric oxide-mediated convective pathways. Am J Physiol 1995; 268: R1060–8
   PubMed Web of Science ®Google Scholar
• Gräfe M, Bossaler C, Graf K, Auch-Schwelk W, Baumgarten C R, Hildebrandt A, et al. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol 1993; 264: H1493–7
   PubMed Web of Science ®Google Scholar
• Tesfamariam B, Cohen R A. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ Res 1988; 63: 720–5
   PubMed Web of Science ®Google Scholar
• Rubanyi G M, Freay A D, Kauser K, Johns A, Harder DR. Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses. Blood Vessels 1990; 27: 246–57
   PubMedGoogle Scholar
• Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar
• Tamaoki J, Sakai A, Kondo M, Takamura H, Konno K. Role of nitric oxide in tachykinin-induced potential difference of rabbit tracheal mucosa. J Physiol 1995; 488: 115–22
   PubMed Web of Science ®Google Scholar
• Eutamene H, Theodorou V, Fiormonti J, Bueno L. Implication of NKi and NK2 receptors in rat colonic hypersecretion induced by interleukin 1β: role of nitric oxide. Gastroenterology 1995; 109: 483–9
   PubMed Web of Science ®Google Scholar
• Benoit J N, Zimmerman Premen A J, Vay Liang W G, Granger N. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986; 251: G674–7
   Google Scholar
• Thornton J R, Dean H, Losowsky MS. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides?. Gut 1988; 29: 1167–72
   PubMed Web of Science ®Google Scholar
• Bendtsen F, Schifter S, Henriksen JH. Increased circulating calcitonin gene-related peptide in cirrhosis. J Hepatol 1991; 12: 118–23
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Staun-Olson P, Fahrenkrug J, Ring-Larsen H. Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds. Scand J Gastroenterol 1980; 15: 787–92
   PubMed Web of Science ®Google Scholar
• Lee F Y, Wang S S, Tsai Y T, Lin H J, Lin H C, Chu C J, et al. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in portal hypertensive rats. J Hepatol 1997; 26: 687–93
   PubMed Web of Science ®Google Scholar
• Kenney T J, Stefan A, Nunes D P, Offner G D, Nikulasson S, Pouthalakis C, et al. Effect of substance P and its receptor antagonist CP-96,345 on systemic arterial and portal pressure in normal and cirrhotic rats. Hepatology 1995; 22: 258A
   Web of Science ®Google Scholar